A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand
DiabCare Asia
DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia
1 other identifier
observational
2,342
1 country
1
Brief Summary
This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Thailand.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 9, 2008
CompletedFirst Posted
Study publicly available on registry
December 10, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedNovember 22, 2016
November 1, 2016
9 months
December 9, 2008
November 21, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Mean blood glucose parameters of diabetic patients
Study start
Secondary Outcomes (4)
Patients' perception will be analysed through patient questionnaire measuring psychological well-being, quality of life and patients' compliant to treatment
Study start
Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about HbA1c test and its goal, anti-diabetic treatment and barriers towards optimum diabetes control
Study start
Duration of diabetes associated with highest number of diabetic complications
Study start
Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy)
Study start
Study Arms (1)
A
Interventions
Eligibility Criteria
Patients with diabetes mellitus being treated at general hospitals, diabetes clinics and referral clinics will be selected according to the inclusion and exclusion criteria.
You may qualify if:
- Diabetic patients registered in the particular centre for more than 12 months.
- Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit.
- Patients willing to sign informed consent form.
You may not qualify if:
- Repetition of any patient as patients should not be included twice for any reason.
- Unwilling to participate or unable to comply with protocol requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novo Nordisk A/Slead
Study Sites (1)
Novo Nordisk Investigational Site
Bangkok, 10500, Thailand
Related Links
Biospecimen
Capillary or venous blood will be drawn for analysing HbA1c.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2008
First Posted
December 10, 2008
Study Start
December 1, 2008
Primary Completion
September 1, 2009
Study Completion
September 1, 2009
Last Updated
November 22, 2016
Record last verified: 2016-11